by Bruce Sylvester – Ibrutinib has significantly outperformed ofatumumab as a second-line therapy for chronic lymphocytic leukemia (CLL), according to a Phase 3 study published on May 31,… read more.
Speaking from the World Transplant Congress 2014 held in San Francisco: Dr Louis Guirado, Fundació Puigvert, Barcelona, Spain.
Professor Wolf Bechstein, Goethe University, Frankfurt, Germany speaking at the World Transplant Congress 2014 in San Francisco.
Professor Wolf Bechstein, Goethe University, Frankfurt, Germany speaking at the World Transplant Congress 2014 in San Francisco.
by Bruce Sylvester: After 13 months of high-dose statin therapy, STEMI (ST Segment Elevation Myocardial Infarction) patients achieved significant reductions in coronary atherosclerosis, researchers reported on Sept. 2,… read more.
by Bruce Sylvester: Two intravenous doses of an iron supplement appears to cause heart failure patients with iron deficiency to achieve significant improvements in functional capacity, quality of… read more.
Report from the ESC Annual Congress by Bruce Sylvester: The investigational monoclonal antibody alirocumab, which significantly lowers cholesterol on top of regular statin therapy, also lowers the incidence… read more.
Professor Wolf Bechstein, Goethe University, Frankfurt, Germany speaking at the World Transplant Congress 2014 in San Francisco.
Report from the European Society of Cardiology Annual Congress in Barcelona by Bruce Sylvester – Results from the PARADIGM-HF trial, presented at ESC 2014 on August 30,2014 and… read more.
By William Bernal, King’s College Hospital, London, UK. Body mass index (BMI; weight in kilograms divided by height in metres squared) is an important measurement for assessing perioperative… read more.
By Irene Scalera et al, Queen Elizabeth Hospital, Birmingham, UK. Using livers from deceased donors over the age of 60 years could provide a means of expanding the… read more.
By Aliaksei Pustavoitau et al, Johns Hopkins University School of Medicine, USA. Although the overall mortality in the first year after liver transplantation is decreasing each year, centres… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
